GILTERITINIB

GILTERITINIB was reported 4079 times

GILTERITINIB is most commonly taken among patients reporting these side effects:

# Side effect Count Frequency
0 WT1 GENE MUTATION 7 0.7778
1 PLATELET-DERIVED GROWTH FACTOR RECEPTOR GENE MUTATION 3 0.5000
2 BILIARY TRACT INFECTION FUNGAL 4 0.4444
3 METAMYELOCYTE PERCENTAGE 2 0.4000
4 GENE MUTATION IDENTIFICATION TEST NEGATIVE 4 0.3077
5 TUMOUR CELL MOBILISATION 3 0.3000
6 FLT3 GENE MUTATION 4 0.2667
7 METAMYELOCYTE COUNT 2 0.2500
8 LEFT ATRIAL HYPERTROPHY 11 0.2200
9 GRAFT VERSUS HOST DISEASE ORAL 9 0.1406
10 DIFFERENTIATION SYNDROME 103 0.1403
11 MORGANELLA TEST POSITIVE 3 0.1250
12 MONOCYTE PERCENTAGE ABNORMAL 2 0.0909
13 ADENOVIRAL ENCEPHALITIS 1 0.0909
14 ACUTE MYELOID LEUKAEMIA RECURRENT 180 0.0838
15 ACUTE MYELOID LEUKAEMIA REFRACTORY 13 0.0756
16 LEPTOTRICHIA INFECTION 3 0.0667
17 PNEUMONIA ADENOVIRAL 13 0.0657
18 SEPTAL PANNICULITIS 5 0.0625
19 BLAST CELL COUNT INCREASED 62 0.0592
20 ELECTROCARDIOGRAM PR SHORTENED 12 0.0571
21 ADENOVIRAL HEPATITIS 13 0.0553
22 BASOPHIL PERCENTAGE DECREASED 2 0.0541
23 ACUTE MACULAR OUTER RETINOPATHY 1 0.0526
24 MYELOBLAST COUNT INCREASED 4 0.0519
25 ASPIRATION BONE MARROW ABNORMAL 7 0.0519
26 ERYTHROBLAST COUNT INCREASED 3 0.0500
27 RADIATION FIBROSIS - LUNG 3 0.0484
28 EUTHYROID SICK SYNDROME 4 0.0471
29 CORYNEBACTERIUM BACTERAEMIA 4 0.0471
30 CAPNOCYTOPHAGA INFECTION 4 0.0426
31 BLAST CELL COUNT DECREASED 3 0.0411
32 NEUTROPHIL PERCENTAGE ABNORMAL 2 0.0400
33 PRE-ENGRAFTMENT IMMUNE REACTION 3 0.0375
34 BIFIDOBACTERIUM INFECTION 1 0.0370
35 LEUKAEMIC INFILTRATION EXTRAMEDULLARY 9 0.0353
36 ADENOVIRAL CONJUNCTIVITIS 1 0.0345
37 GLOBULIN ABNORMAL 2 0.0345
38 DELAYED HAEMOLYTIC TRANSFUSION REACTION 2 0.0339
39 MEAN CELL HAEMOGLOBIN CONCENTRATION 2 0.0328
40 ACUTE GRAFT VERSUS HOST DISEASE ORAL 1 0.0323
41 CENTRAL NERVOUS SYSTEM LEUKAEMIA 12 0.0305
42 IMMUNOSUPPRESSANT DRUG LEVEL ABNORMAL 2 0.0303
43 LYMPHOCYTE PERCENTAGE ABNORMAL 2 0.0290
44 LEUKAEMIC INFILTRATION 4 0.0286
45 NONINFECTIVE SIALOADENITIS 4 0.0252
46 GRAFT VERSUS HOST DISEASE IN LIVER 18 0.0251
47 CHRONIC GRAFT VERSUS HOST DISEASE ORAL 6 0.0245
48 DISSEMINATED ASPERGILLOSIS 11 0.0233
49 MYELOCYTOSIS 2 0.0233
50 CHRONIC GRAFT VERSUS HOST DISEASE IN LUNG 4 0.0231
51 BLAST CELLS PRESENT 11 0.0229
52 MINIMAL RESIDUAL DISEASE 11 0.0228
53 TUMOUR ASSOCIATED FEVER 9 0.0220
54 ACUTE MYELOID LEUKAEMIA 342 0.0219
55 TRANSPLANTATION COMPLICATION 9 0.0214
56 GRAFT VERSUS HOST DISEASE IN SKIN 47 0.0213
57 ACQUIRED AMEGAKARYOCYTIC THROMBOCYTOPENIA 1 0.0208
58 BK POLYOMAVIRUS TEST POSITIVE 2 0.0208
59 BLOOD ERYTHROPOIETIN INCREASED 2 0.0202
60 IMAGING PROCEDURE ABNORMAL 2 0.0200
61 BLOOD IMMUNOGLOBULIN M ABNORMAL 2 0.0194
62 OESOPHAGEAL INTRAMURAL HAEMATOMA 2 0.0190
63 CHLOROMA 8 0.0190
64 BACILLUS BACTERAEMIA 2 0.0183
65 AUTOIMMUNE ANAEMIA 1 0.0182
66 INTERSTITIAL LUNG ABNORMALITY 2 0.0175
67 ENGRAFT FAILURE 5 0.0174
68 CENTRAL NERVOUS SYSTEM FUNGAL INFECTION 4 0.0172
69 GRAFT VERSUS HOST DISEASE IN GASTROINTESTINAL TRACT 36 0.0169
70 CYSTITIS VIRAL 6 0.0157
71 CHRONIC GRAFT VERSUS HOST DISEASE IN EYE 3 0.0148
72 MONOCYTOSIS 9 0.0145
73 GEOTRICHUM INFECTION 3 0.0142
74 ACUTE FEBRILE NEUTROPHILIC DERMATOSIS 33 0.0142
75 ENTEROCOCCAL BACTERAEMIA 15 0.0142
76 CHRONIC GRAFT VERSUS HOST DISEASE IN LIVER 5 0.0137
77 DILATATION INTRAHEPATIC DUCT ACQUIRED 4 0.0137
78 CYTOPENIA 167 0.0136
79 ANTIVIRAL DRUG LEVEL ABOVE THERAPEUTIC 1 0.0133
80 GRAFT VERSUS HOST DISEASE IN EYE 3 0.0130
81 LEUKAEMIA CUTIS 2 0.0130
82 CHRONIC GRAFT VERSUS HOST DISEASE IN SKIN 12 0.0130
83 CONGENITAL APLASIA 4 0.0129
84 ALLOGENIC STEM CELL TRANSPLANTATION 2 0.0127
85 GRAFT VERSUS HOST DISEASE IN LUNG 6 0.0126
86 MEAN CELL HAEMOGLOBIN CONCENTRATION ABNORMAL 2 0.0124
87 BACTERIAL TRACHEITIS 1 0.0123
88 BLOOD IMMUNOGLOBULIN G ABNORMAL 2 0.0120
89 ENGRAFTMENT SYNDROME 7 0.0118
90 ANTITHROMBIN III DEFICIENCY 1 0.0112
91 DRUG RESISTANCE MUTATION 2 0.0112
92 ACUTE MONOCYTIC LEUKAEMIA 2 0.0110
93 GRAFT VERSUS HOST DISEASE 79 0.0110
94 METASTASES TO NERVOUS SYSTEM 2 0.0109
95 MUSCULOSKELETAL TOXICITY 2 0.0108
96 HUMAN HERPESVIRUS 6 ENCEPHALITIS 3 0.0106
97 CHRONIC GRAFT VERSUS HOST DISEASE IN INTESTINE 2 0.0105
98 RED CELL DISTRIBUTION WIDTH ABNORMAL 2 0.0105
99 BIOPSY BREAST ABNORMAL 1 0.0105
100 FIBRIN DEGRADATION PRODUCTS INCREASED 3 0.0101
101 NEUTROPHILIC DERMATOSIS 4 0.0101
102 PNEUMONIA FUNGAL 39 0.0099
103 ACUTE GRAFT VERSUS HOST DISEASE IN SKIN 27 0.0098
104 THROMBOPHLEBITIS SEPTIC 2 0.0098
105 ASPERGILLUS TEST POSITIVE 3 0.0097
106 ACUTE GRAFT VERSUS HOST DISEASE IN LIVER 7 0.0097
107 SALMONELLA BACTERAEMIA 2 0.0097
108 ADENOVIRAL HAEMORRHAGIC CYSTITIS 2 0.0096
109 PERICARDITIS CONSTRICTIVE 4 0.0095
110 FEMALE REPRODUCTIVE TRACT DISORDER 2 0.0092
111 SEROSITIS 5 0.0090
112 MONOCYTE COUNT ABNORMAL 2 0.0090
113 LABELLED DRUG-DRUG INTERACTION ISSUE 13 0.0090
114 MYOPERICARDITIS 7 0.0090
115 METAPNEUMOVIRUS INFECTION 7 0.0089
116 MYELOSUPPRESSION 312 0.0087
117 HAIRY CELL LEUKAEMIA 2 0.0086
118 MUCOSAL DISORDER 8 0.0080
119 REMISSION NOT ACHIEVED 5 0.0080
120 KLEBSIELLA SEPSIS 9 0.0080
121 ACUTE GRAFT VERSUS HOST DISEASE IN INTESTINE 11 0.0078
122 LEUKAEMIA RECURRENT 13 0.0077
123 CHRONIC GRAFT VERSUS HOST DISEASE 27 0.0075
124 ACUTE LYMPHOCYTIC LEUKAEMIA REFRACTORY 1 0.0074
125 ATOPY 2 0.0072
126 ANAEMIA OF MALIGNANT DISEASE 2 0.0071
127 CEREBRAL FUNGAL INFECTION 2 0.0071
128 CARDIORENAL SYNDROME 4 0.0070
129 HYPERFERRITINAEMIA 3 0.0070
130 MOUTH BREATHING 3 0.0069
131 IDIOPATHIC PNEUMONIA SYNDROME 2 0.0067
132 BLOOD BETA-D-GLUCAN INCREASED 2 0.0065
133 ALPHA HAEMOLYTIC STREPTOCOCCAL INFECTION 6 0.0065
134 LUNG OPACITY 17 0.0064
135 URINARY TRACT INFECTION ENTEROCOCCAL 6 0.0064
136 CARBON DIOXIDE ABNORMAL 2 0.0064
137 PULMONARY VASCULAR DISORDER 3 0.0064
138 ENTEROCOCCAL SEPSIS 5 0.0062
139 CHRONIC MYELOMONOCYTIC LEUKAEMIA 4 0.0061
140 BLAST CELL CRISIS 2 0.0060
141 MYELOID LEUKAEMIA 3 0.0060
142 COMPLICATIONS OF TRANSPLANT SURGERY 3 0.0059
143 ADENOVIRUS INFECTION 17 0.0059
144 PULMONARY VENO-OCCLUSIVE DISEASE 4 0.0057
145 ACUTE GRAFT VERSUS HOST DISEASE 26 0.0057
146 SCEDOSPORIUM INFECTION 4 0.0057
147 HYPERLEUKOCYTOSIS 5 0.0056
148 IRON OVERLOAD 6 0.0056
149 COMPLICATIONS OF BONE MARROW TRANSPLANT 2 0.0055
150 PITYRIASIS ROSEA 2 0.0054
151 ATYPICAL PNEUMONIA 16 0.0053
152 EPSTEIN-BARR VIRUS INFECTION REACTIVATION 7 0.0053
153 CREATINE KINASE INCREASED 4 0.0052
154 AMYLASE INCREASED 19 0.0051
155 FEBRILE INFECTION 6 0.0051
156 ELECTROCARDIOGRAM ST SEGMENT DEPRESSION 11 0.0050
157 BONE ABSCESS 2 0.0049
158 ACOUSTIC NEUROMA 2 0.0049
159 PERIORBITAL HAEMATOMA 4 0.0049
160 CANDIDA TEST POSITIVE 2 0.0048
161 GENE MUTATION IDENTIFICATION TEST POSITIVE 2 0.0048
162 BACTERAEMIA 56 0.0047
163 BRONCHOPULMONARY ASPERGILLOSIS 36 0.0046
164 APLASIA 9 0.0046
165 OBLITERATIVE BRONCHIOLITIS 6 0.0046
166 FUSARIUM INFECTION 3 0.0043
167 ESCHERICHIA BACTERAEMIA 10 0.0042
168 WOLFF-PARKINSON-WHITE SYNDROME 2 0.0042
169 MEAN CELL VOLUME ABNORMAL 2 0.0042
170 ABSENCE OF IMMEDIATE TREATMENT RESPONSE 1 0.0042
171 VIRAL HAEMORRHAGIC CYSTITIS 3 0.0042
172 KLEBSIELLA BACTERAEMIA 4 0.0042
173 ESCHERICHIA TEST POSITIVE 5 0.0042
174 BRONCHIAL WALL THICKENING 3 0.0042
175 PHILADELPHIA CHROMOSOME POSITIVE 3 0.0041
176 CYTOMEGALOVIRUS INFECTION REACTIVATION 18 0.0041
177 CARDIAC DYSFUNCTION 15 0.0040
178 EOSINOPHIL COUNT ABNORMAL 3 0.0040
179 ELECTROCARDIOGRAM QT INTERVAL ABNORMAL 2 0.0040
180 ANORECTAL INFECTION 1 0.0040
181 ANAL INFECTION 1 0.0039
182 PLATELET TRANSFUSION 5 0.0039
183 NEUTROPENIC COLITIS 8 0.0039
184 FEBRILE NEUTROPENIA 252 0.0038
185 BLOOD DISORDER 30 0.0037
186 PERIORBITAL CELLULITIS 2 0.0037
187 STENOTROPHOMONAS INFECTION 5 0.0037
188 GASTROENTERITIS ESCHERICHIA COLI 2 0.0037
189 FUNGAL SEPSIS 3 0.0036
190 SEPTIC EMBOLUS 3 0.0036
191 BLOOD LACTATE DEHYDROGENASE INCREASED 57 0.0036
192 MYOCARDIAL NECROSIS MARKER INCREASED 6 0.0036
193 MYOCARDIAL INJURY 4 0.0036
194 TUMOUR LYSIS SYNDROME 31 0.0035
195 INTENSIVE CARE 5 0.0035
196 INFECTION REACTIVATION 4 0.0035
197 NEUTROPHIL COUNT DECREASED 141 0.0035
198 HEPATIC FUNCTION ABNORMAL 128 0.0034
199 PSEUDOMONAL SEPSIS 6 0.0034
200 INCORRECT PRODUCT FORMULATION ADMINISTERED 3 0.0034
201 ALVEOLAR PROTEINOSIS 2 0.0034
202 CAMPYLOBACTER GASTROENTERITIS 2 0.0034
203 FEBRILE BONE MARROW APLASIA 14 0.0033
204 ASPARTATE AMINOTRANSFERASE ABNORMAL 5 0.0033
205 PSOAS ABSCESS 2 0.0032
206 ELECTROCARDIOGRAM QT PROLONGED 114 0.0032
207 NEUTROPENIC INFECTION 3 0.0031
208 ASPERGILLOMA 1 0.0031
209 ENTEROCOCCAL INFECTION 15 0.0031
210 PNEUMONIA CYTOMEGALOVIRAL 6 0.0031
211 ACUTE LEFT VENTRICULAR FAILURE 2 0.0030
212 ORGAN FAILURE 12 0.0030
213 BK VIRUS INFECTION 10 0.0030
214 NON-CARDIOGENIC PULMONARY OEDEMA 3 0.0028
215 HEPATIC CYTOLYSIS 36 0.0028
216 CYTOMEGALOVIRUS TEST POSITIVE 5 0.0028
217 PLATELET COUNT DECREASED 298 0.0028
218 KLEBSIELLA INFECTION 14 0.0028
219 PANCREATIC ENZYMES INCREASED 4 0.0027
220 SOFT TISSUE INFECTION 5 0.0027
221 LYMPH NODE TUBERCULOSIS 2 0.0027
222 SERRATIA INFECTION 2 0.0027
223 FULL BLOOD COUNT DECREASED 54 0.0027
224 PNEUMONIA PSEUDOMONAL 4 0.0026
225 OSTEOCHONDROSIS 3 0.0026
226 ERYTHEMA NODOSUM 9 0.0026
227 WHITE BLOOD CELL COUNT ABNORMAL 16 0.0025
228 HAEMATOMA MUSCLE 3 0.0025
229 DYSPLASIA 3 0.0025
230 RENAL TUBULAR INJURY 3 0.0025
231 SECONDARY IMMUNODEFICIENCY 3 0.0025
232 STARVATION 2 0.0024
233 HAEMOPHAGOCYTIC LYMPHOHISTIOCYTOSIS 18 0.0024
234 LUNG INFILTRATION 21 0.0024
235 PNEUMONIA RESPIRATORY SYNCYTIAL VIRAL 2 0.0024
236 STAPHYLOCOCCUS TEST POSITIVE 5 0.0024
237 ALANINE AMINOTRANSFERASE ABNORMAL 5 0.0024
238 BONE SCAN ABNORMAL 1 0.0024
239 NOCARDIOSIS 6 0.0023
240 PSEUDOMONAL BACTERAEMIA 2 0.0023
241 BLOOD CREATININE ABNORMAL 8 0.0023
242 TRANSFUSION REACTION 2 0.0023
243 PANCYTOPENIA 126 0.0023
244 PSEUDOMEMBRANOUS COLITIS 5 0.0022
245 CYSTITIS HAEMORRHAGIC 9 0.0022
246 BLOOD ALKALINE PHOSPHATASE ABNORMAL 2 0.0022
247 BLOOD CREATINE PHOSPHOKINASE ABNORMAL 1 0.0022
248 PNEUMOMEDIASTINUM 4 0.0022
249 HEPATOTOXICITY 49 0.0022
250 BONE INFARCTION 1 0.0022
251 ENTEROCOLITIS INFECTIOUS 2 0.0022
252 LIVER ABSCESS 7 0.0022
253 BACTERIAL SEPSIS 7 0.0021
254 BIOPSY BONE MARROW 1 0.0021
255 BLOOD UREA ABNORMAL 2 0.0021
256 BLOOD CREATINE PHOSPHOKINASE INCREASED 61 0.0021
257 CATHETER SITE INFECTION 8 0.0021
258 ELECTROCARDIOGRAM ST SEGMENT ELEVATION 7 0.0021
259 TRANSPLANT 5 0.0021
260 INVESTIGATION ABNORMAL 3 0.0021
261 HEPATIC MASS 4 0.0021
262 HAEMATOLOGICAL INFECTION 5 0.0020
263 DEVICE RELATED THROMBOSIS 2 0.0020
264 CHOLANGIOCARCINOMA 3 0.0020
265 GASTRITIS HAEMORRHAGIC 3 0.0020
266 SYSTEMIC CANDIDA 5 0.0020
267 BONE MARROW FAILURE 40 0.0020
268 PHYSICAL DECONDITIONING 5 0.0019
269 FUNGAEMIA 3 0.0019
270 ENTEROCOLITIS 11 0.0019
271 URETEROLITHIASIS 2 0.0019
272 POLYOMAVIRUS VIRAEMIA 2 0.0019
273 HYPERTENSIVE NEPHROPATHY 2 0.0019
274 STREPTOCOCCAL BACTERAEMIA 2 0.0018
275 CEREBELLAR INFARCTION 3 0.0018
276 CYTOGENETIC ABNORMALITY 2 0.0018
277 SUSPECTED OFF LABEL USE 8 0.0018
278 SEPTIC SHOCK 77 0.0018
279 NEUTROPHIL COUNT ABNORMAL 5 0.0018
280 THROMBOTIC MICROANGIOPATHY 17 0.0017
281 MYCOBACTERIAL INFECTION 3 0.0017
282 MULTIPLE ORGAN DYSFUNCTION SYNDROME 48 0.0017
283 HERPES SIMPLEX 11 0.0017
284 HAEMATOTOXICITY 16 0.0017
285 CARDIOTOXICITY 15 0.0017
286 PNEUMONIA INFLUENZAL 2 0.0017
287 ASPERGILLUS INFECTION 11 0.0017
288 IMMUNOSUPPRESSANT DRUG LEVEL DECREASED 2 0.0017
289 BONE MARROW DISORDER 5 0.0017
290 HYPERPYREXIA 7 0.0017
291 PANNICULITIS 4 0.0017
292 CLOSTRIDIUM COLITIS 2 0.0016
293 FEBRILE CONVULSION 2 0.0016
294 DISSEMINATED INTRAVASCULAR COAGULATION 23 0.0016
295 LARGE INTESTINE INFECTION 2 0.0016
296 HAEMATOCRIT ABNORMAL 2 0.0016
297 LIVER DISORDER 72 0.0016
298 VENOOCCLUSIVE LIVER DISEASE 8 0.0016
299 INTRA-ABDOMINAL HAEMATOMA 2 0.0016
300 LUPUS NEPHRITIS 3 0.0016
301 STEM CELL TRANSPLANT 4 0.0016
302 VENOOCCLUSIVE DISEASE 4 0.0016
303 BACILLUS INFECTION 1 0.0016
304 BRAIN ABSCESS 4 0.0016
305 HEPATIC INFECTION 2 0.0016
306 ACTIVITIES OF DAILY LIVING DECREASED 1 0.0016
307 PORTAL VEIN THROMBOSIS 5 0.0015
308 ABDOMINAL WALL ABSCESS 1 0.0015
309 UNDERDOSE 112 0.0015
310 DISEASE COMPLICATION 7 0.0015
311 PRODUCT INEFFECTIVE FOR UNAPPROVED USE 4 0.0015
312 DEVICE RELATED SEPSIS 3 0.0015
313 TRANSAMINASES INCREASED 33 0.0015
314 BLOOD PHOSPHORUS INCREASED 4 0.0015
315 ESCHERICHIA INFECTION 12 0.0015
316 CAPILLARY LEAK SYNDROME 3 0.0014
317 BRAIN CANCER METASTATIC 1 0.0014
318 LIVEDO RETICULARIS 3 0.0014
319 LIPASE INCREASED 11 0.0014
320 PULMONARY ALVEOLAR HAEMORRHAGE 8 0.0014
321 URINARY BLADDER HAEMORRHAGE 3 0.0014
322 ATYPICAL MYCOBACTERIAL INFECTION 2 0.0014
323 GLOMERULAR FILTRATION RATE ABNORMAL 2 0.0014
324 SUBDURAL HAEMATOMA 20 0.0014
325 HYPERPHOSPHATAEMIA 3 0.0014
326 EXOPHTHALMOS 3 0.0014
327 PNEUMOCYSTIS JIROVECII PNEUMONIA 14 0.0014
328 ESCHERICHIA SEPSIS 4 0.0014
329 BLOOD FOLATE DECREASED 1 0.0014
330 BACTERIAL DISEASE CARRIER 1 0.0014
331 THROMBOCYTOPENIA 152 0.0014
332 ENTEROCOLITIS HAEMORRHAGIC 2 0.0014
333 PRODUCT USE ISSUE 254 0.0014
334 GASTROINTESTINAL WALL THICKENING 2 0.0013
335 STEROID DIABETES 2 0.0013
336 SERUM FERRITIN INCREASED 7 0.0013
337 MYELOFIBROSIS 4 0.0013
338 FIBROSIS 4 0.0013
339 BACTERIAL INFECTION 24 0.0013
340 PNEUMONIA LEGIONELLA 2 0.0012
341 GUILLAIN-BARRE SYNDROME 6 0.0012
342 FUNGAL SKIN INFECTION 5 0.0012
343 MOUTH HAEMORRHAGE 9 0.0012
344 ANAL ULCER 1 0.0012
345 TRANSPLANT FAILURE 3 0.0012
346 EJECTION FRACTION DECREASED 19 0.0012
347 MYOCARDITIS 14 0.0012
348 HYPERVOLAEMIA 6 0.0012
349 TROPONIN I INCREASED 2 0.0012
350 SEPSIS 133 0.0012
351 ENTEROBACTER INFECTION 2 0.0012
352 PLATELET DISORDER 3 0.0012
353 SKIN WOUND 2 0.0012
354 APTYALISM 1 0.0012
355 HEPATOSPLENOMEGALY 3 0.0012
356 LEUKAEMIA 11 0.0012
357 LEUKOCYTOSIS 21 0.0012
358 PERIORBITAL OEDEMA 6 0.0012
359 MUCORMYCOSIS 3 0.0012
360 POSTERIOR REVERSIBLE ENCEPHALOPATHY SYNDROME 11 0.0012
361 WHITE BLOOD CELL COUNT INCREASED 44 0.0011
362 MELAENA 25 0.0011
363 GASTROINTESTINAL OEDEMA 2 0.0011
364 EPSTEIN-BARR VIRUS ASSOCIATED LYMPHOPROLIFERATIVE DISORDER 2 0.0011
365 PULMONARY TOXICITY 8 0.0011
366 HISTOPLASMOSIS 2 0.0011
367 WHITE BLOOD CELL COUNT DECREASED 122 0.0011
368 JUGULAR VEIN THROMBOSIS 2 0.0011
369 NEUTROPENIC SEPSIS 8 0.0011
370 INFECTION 161 0.0011
371 PYODERMA GANGRENOSUM 4 0.0011
372 LARGE INTESTINAL ULCER 3 0.0011
373 ANEURYSM RUPTURED 1 0.0011
374 PNEUMONIA KLEBSIELLA 2 0.0011
375 BIOPSY 1 0.0011
376 LUNG CONSOLIDATION 3 0.0011
377 LIVER FUNCTION TEST INCREASED 23 0.0011
378 ENDOTRACHEAL INTUBATION 3 0.0011
379 HYPERTENSIVE HEART DISEASE 2 0.0011
380 NEUTROPENIA 144 0.0011
381 HUMAN HERPESVIRUS 6 INFECTION 2 0.0011
382 CHEMOTHERAPY 4 0.0011
383 BONE MARROW TRANSPLANT 2 0.0011
384 EARLY SATIETY 2 0.0010
385 LYMPHOPROLIFERATIVE DISORDER 3 0.0010
386 TOOTH DISCOLOURATION 3 0.0010
387 HYPERTRANSAMINASAEMIA 7 0.0010
388 EMPYEMA 2 0.0010
389 HEPATIC ENZYME ABNORMAL 5 0.0010
390 PATHOGEN RESISTANCE 9 0.0010
391 PRODUCT ADMINISTERED TO PATIENT OF INAPPROPRIATE AGE 6 0.0010
392 SHOCK HAEMORRHAGIC 8 0.0010
393 PNEUMONIA BACTERIAL 9 0.0010
394 ACUTE PROMYELOCYTIC LEUKAEMIA 1 0.0010
395 VARICELLA ZOSTER VIRUS INFECTION 2 0.0010
396 TRANSFUSION 10 0.0010
397 INTERSTITIAL LUNG DISEASE 46 0.0009
398 NEUROGENIC BLADDER 2 0.0009
399 AMAUROSIS FUGAX 1 0.0009
400 ACINETOBACTER INFECTION 1 0.0009
401 IMMUNOSUPPRESSANT DRUG LEVEL INCREASED 3 0.0009
402 OTITIS MEDIA 3 0.0009
403 IMMUNOSUPPRESSION 8 0.0009
404 ILEUS PARALYTIC 4 0.0009
405 CEREBRAL HAEMORRHAGE 32 0.0009
406 HAEMOLYTIC ANAEMIA 8 0.0009
407 PERICARDITIS 15 0.0009
408 BLOOD BILIRUBIN INCREASED 24 0.0009
409 TONGUE ULCERATION 3 0.0009
410 PAPILLOEDEMA 4 0.0009
411 GRANULOCYTOPENIA 5 0.0009
412 INAPPROPRIATE ANTIDIURETIC HORMONE SECRETION 9 0.0009
413 LUMBAR VERTEBRAL FRACTURE 4 0.0009
414 LEFT VENTRICULAR FAILURE 3 0.0009
415 PNEUMONIA 282 0.0009
416 CYTOMEGALOVIRUS COLITIS 2 0.0009
417 AGRANULOCYTOSIS 16 0.0009
418 DRUG-INDUCED LIVER INJURY 27 0.0009
419 BILIRUBIN CONJUGATED INCREASED 2 0.0009
420 THROMBOPHLEBITIS 3 0.0009
421 HAEMORRHAGE SUBCUTANEOUS 3 0.0008
422 EMBOLISM 7 0.0008
423 CYTOMEGALOVIRUS INFECTION 14 0.0008
424 CARDIAC TAMPONADE 4 0.0008
425 GASTROINTESTINAL TOXICITY 4 0.0008
426 ASPARTATE AMINOTRANSFERASE INCREASED 44 0.0008
427 BLAST CRISIS IN MYELOGENOUS LEUKAEMIA 1 0.0008
428 RESPIRATORY FAILURE 59 0.0008
429 ORGANISING PNEUMONIA 4 0.0008
430 LEUKOENCEPHALOPATHY 3 0.0008
431 ALANINE AMINOTRANSFERASE INCREASED 49 0.0008
432 CHOLESTASIS 15 0.0008
433 OESOPHAGEAL ULCER 3 0.0008
434 BILIARY OBSTRUCTION 1 0.0008
435 OPTIC NEURITIS 7 0.0008
436 COVID-19 PNEUMONIA 9 0.0008
437 FULL BLOOD COUNT ABNORMAL 8 0.0008
438 CHOLECYSTITIS 9 0.0008
439 CLOSTRIDIUM DIFFICILE COLITIS 8 0.0008
440 PYREXIA 261 0.0008
441 HEPATITIS 19 0.0007
442 PERICARDIAL EFFUSION 17 0.0007
443 CLOSTRIDIUM DIFFICILE INFECTION 16 0.0007
444 ARTHRITIS BACTERIAL 3 0.0007
445 DRUG LEVEL INCREASED 12 0.0007
446 VITREOUS HAEMORRHAGE 2 0.0007
447 BILIARY TRACT DISORDER 1 0.0007
448 FUNGAL INFECTION 24 0.0007
449 BLOOD ELECTROLYTES DECREASED 1 0.0007
450 PSEUDOMONAS INFECTION 6 0.0007
451 HEART VALVE INCOMPETENCE 2 0.0007
452 CELLULITIS 35 0.0007
453 ENCEPHALOPATHY 17 0.0007
454 RENAL IMPAIRMENT 58 0.0007
455 MUCOSAL INFLAMMATION 18 0.0007
456 SUBARACHNOID HAEMORRHAGE 7 0.0007
457 AUTONOMIC NERVOUS SYSTEM IMBALANCE 2 0.0007
458 SARS-COV-2 TEST POSITIVE 9 0.0007
459 ABDOMINAL ABSCESS 3 0.0007
460 PURPURA 6 0.0007
461 HYPERBILIRUBINAEMIA 7 0.0007
462 ACUTE RESPIRATORY FAILURE 13 0.0007
463 CYTOMEGALOVIRUS VIRAEMIA 3 0.0007
464 PLEURAL EFFUSION 41 0.0007
465 THERAPY NON-RESPONDER 30 0.0007
466 HEPATITIS CHOLESTATIC 4 0.0007
467 DRUG RESISTANCE 17 0.0007
468 VASCULAR DEVICE INFECTION 3 0.0007
469 GINGIVAL BLEEDING 9 0.0007
470 ACIDOSIS 5 0.0007
471 CHEST X-RAY ABNORMAL 2 0.0007
472 ANAEMIA 124 0.0006
473 DEVICE RELATED INFECTION 10 0.0006
474 PULMONARY OEDEMA 29 0.0006
475 HAEMOLYSIS 5 0.0006
476 CHOLANGITIS 4 0.0006
477 HAEMOGLOBIN DECREASED 66 0.0006
478 OESOPHAGITIS 7 0.0006
479 STAPHYLOCOCCAL INFECTION 21 0.0006
480 ENTERITIS 4 0.0006
481 HYPOXIA 22 0.0006
482 HAEMOGLOBIN ABNORMAL 4 0.0006
483 ACUTE LEUKAEMIA 1 0.0006
484 STAPHYLOCOCCAL SEPSIS 3 0.0006
485 PROGRESSIVE MULTIFOCAL LEUKOENCEPHALOPATHY 5 0.0006
486 C-REACTIVE PROTEIN INCREASED 22 0.0006
487 GASTROINTESTINAL HAEMORRHAGE 50 0.0006
488 NEPHROTIC SYNDROME 4 0.0006
489 OFF LABEL USE 508 0.0006
490 ACUTE SINUSITIS 1 0.0006
491 PYELONEPHRITIS 5 0.0006
492 PULMONARY HYPERTENSION 12 0.0006
493 DERMATITIS EXFOLIATIVE GENERALISED 2 0.0006
494 OEDEMA 31 0.0006
495 MOUTH ULCERATION 12 0.0006
496 ACUTE RESPIRATORY DISTRESS SYNDROME 10 0.0006
497 ANAL FISTULA 3 0.0006
498 HAEMORRHAGIC DIATHESIS 2 0.0006
499 COMPRESSION FRACTURE 3 0.0006
500 RED BLOOD CELL COUNT DECREASED 16 0.0006
501 CARDIOGENIC SHOCK 8 0.0006
502 FACIAL BONES FRACTURE 2 0.0006
503 MONOCYTE COUNT INCREASED 2 0.0006
504 LIVER FUNCTION TEST ABNORMAL 16 0.0005
505 VENTRICULAR ARRHYTHMIA 2 0.0005
506 IMMUNE-MEDIATED ENTEROCOLITIS 2 0.0005
507 BODY TEMPERATURE ABNORMAL 1 0.0005
508 CARDIOMYOPATHY 8 0.0005
509 LOWER GASTROINTESTINAL HAEMORRHAGE 4 0.0005
510 SKIN INFECTION 6 0.0005
511 SKIN TOXICITY 3 0.0005
512 AUTOIMMUNE THYROIDITIS 2 0.0005
513 INTERNAL HAEMORRHAGE 6 0.0005
514 CONJUNCTIVAL HAEMORRHAGE 2 0.0005
515 LEUKOPENIA 26 0.0005
516 BLOOD URIC ACID INCREASED 3 0.0005
517 HYPOALBUMINAEMIA 4 0.0005
518 MUSCLE RUPTURE 2 0.0005
519 ORAL INFECTION 2 0.0005
520 THERAPEUTIC RESPONSE DECREASED 31 0.0005
521 BICYTOPENIA 1 0.0005
522 HYPOMAGNESAEMIA 7 0.0005
523 OESOPHAGEAL CANDIDIASIS 2 0.0005
524 DISEASE PROGRESSION 59 0.0005
525 RECURRENT CANCER 2 0.0005
526 LIVER INJURY 12 0.0005
527 HYPERURICAEMIA 2 0.0005
528 HEPATIC ENZYME INCREASED 33 0.0005
529 GASTROINTESTINAL PERFORATION 2 0.0005
530 EPSTEIN-BARR VIRUS INFECTION 3 0.0005
531 UPPER GASTROINTESTINAL HAEMORRHAGE 8 0.0005
532 CANDIDA INFECTION 8 0.0005
533 ESCHERICHIA URINARY TRACT INFECTION 2 0.0005
534 IMMUNODEFICIENCY 7 0.0005
535 ABSCESS LIMB 2 0.0005
536 ANAEMIA MACROCYTIC 1 0.0005
537 HAEMORRHAGE INTRACRANIAL 7 0.0005
538 C-REACTIVE PROTEIN ABNORMAL 3 0.0005
539 BLOOD POTASSIUM DECREASED 14 0.0005
540 HEPATIC LESION 2 0.0005
541 ALTERED STATE OF CONSCIOUSNESS 10 0.0005
542 GENERAL PHYSICAL HEALTH DETERIORATION 53 0.0005
543 DIVERTICULUM INTESTINAL 2 0.0005
544 PULMONARY FUNCTION TEST DECREASED 2 0.0005
545 MENINGITIS 3 0.0004
546 LEFT VENTRICULAR DYSFUNCTION 3 0.0004
547 ADENOCARCINOMA 1 0.0004
548 TASTE DISORDER 9 0.0004
549 BODY TEMPERATURE INCREASED 9 0.0004
550 HAEMOGLOBIN INCREASED 2 0.0004
551 BUNDLE BRANCH BLOCK RIGHT 2 0.0004
552 BRAIN NEOPLASM 4 0.0004
553 LYMPHOEDEMA 3 0.0004
554 HAEMOPTYSIS 12 0.0004
555 ROSACEA 2 0.0004
556 DRUG INTERACTION 68 0.0004
557 PAPULE 3 0.0004
558 DISEASE RECURRENCE 20 0.0004
559 SUBCUTANEOUS ABSCESS 2 0.0004
560 NERVOUS SYSTEM DISORDER 13 0.0004
561 BLOOD CREATININE INCREASED 27 0.0004
562 RENAL CELL CARCINOMA 2 0.0004
563 SENSITIVE SKIN 3 0.0004
564 HYPOPHOSPHATAEMIA 3 0.0004
565 HOSPICE CARE 4 0.0004
566 BLOOD IMMUNOGLOBULIN G DECREASED 1 0.0004
567 INFLAMMATORY MARKER INCREASED 2 0.0004
568 ERYSIPELAS 2 0.0004
569 APPENDICITIS PERFORATED 1 0.0004
570 HYPOKALAEMIA 18 0.0004
571 PRODUCT TEMPERATURE EXCURSION ISSUE 2 0.0004
572 ACUTE LYMPHOCYTIC LEUKAEMIA RECURRENT 1 0.0004
573 THERAPY PARTIAL RESPONDER 6 0.0004
574 PETECHIAE 4 0.0004
575 PRODUCT USE COMPLAINT 6 0.0004
576 ORAL CANDIDIASIS 5 0.0004
577 PULMONARY CONGESTION 5 0.0004
578 COVID-19 66 0.0004
579 ATRIAL FLUTTER 3 0.0004
580 ANIMAL BITE 1 0.0004
581 ANAL ABSCESS 2 0.0004
582 RESPIRATORY DISORDER 11 0.0004
583 BLOOD ALKALINE PHOSPHATASE INCREASED 9 0.0004
584 ANGIOPATHY 2 0.0004
585 ACUTE PULMONARY OEDEMA 2 0.0004
586 BLOOD CALCIUM DECREASED 4 0.0004
587 STATUS EPILEPTICUS 4 0.0004
588 PRESCRIBED UNDERDOSE 7 0.0004
589 ANURIA 3 0.0003
590 GASTRIC HAEMORRHAGE 4 0.0003
591 EXERCISE TOLERANCE DECREASED 2 0.0003
592 LUNG DISORDER 17 0.0003
593 RESPIRATORY SYNCYTIAL VIRUS INFECTION 3 0.0003
594 ELECTROLYTE IMBALANCE 4 0.0003
595 HYPERTRIGLYCERIDAEMIA 2 0.0003
596 FEELING OF BODY TEMPERATURE CHANGE 2 0.0003
597 GASTROINTESTINAL INFECTION 3 0.0003
598 BLOOD CULTURE POSITIVE 1 0.0003
599 PLATELET COUNT ABNORMAL 2 0.0003
600 CEREBRAL INFARCTION 8 0.0003
601 UROSEPSIS 3 0.0003
602 SKIN CANCER 7 0.0003
603 LARYNGEAL OEDEMA 2 0.0003
604 BRAIN NATRIURETIC PEPTIDE INCREASED 1 0.0003
605 GENERALISED OEDEMA 4 0.0003
606 OLIGURIA 2 0.0003
607 ILEUS 4 0.0003
608 APPENDICITIS 3 0.0003
609 ACUTE KIDNEY INJURY 49 0.0003
610 BLOOD CREATININE DECREASED 1 0.0003
611 DEATH 273 0.0003
612 GAMMA-GLUTAMYLTRANSFERASE INCREASED 7 0.0003
613 RASH MACULO-PAPULAR 7 0.0003
614 BILE DUCT STONE 1 0.0003
615 CARDIAC FAILURE 25 0.0003
616 DIZZINESS POSTURAL 3 0.0003
617 HAEMATOMA 8 0.0003
618 AUTOIMMUNE DISORDER 3 0.0003
619 RESPIRATORY TRACT INFECTION 8 0.0003
620 MALIGNANT NEOPLASM PROGRESSION 31 0.0003
621 COAGULOPATHY 5 0.0003
622 SKIN MASS 2 0.0003
623 CYTOKINE RELEASE SYNDROME 6 0.0003
624 FACE OEDEMA 5 0.0003
625 TACHYCARDIA 26 0.0003
626 HAEMATURIA 10 0.0003
627 AUTOIMMUNE HAEMOLYTIC ANAEMIA 1 0.0003
628 ECCHYMOSIS 2 0.0003
629 ONYCHOCLASIS 2 0.0003
630 COLITIS 11 0.0003
631 VENTRICULAR EXTRASYSTOLES 3 0.0003
632 AORTIC STENOSIS 1 0.0003
633 SCRATCH 3 0.0003
634 DRUG ERUPTION 5 0.0003
635 PNEUMONIA ASPIRATION 7 0.0003
636 BONE LESION 1 0.0003
637 MYELODYSPLASTIC SYNDROME 4 0.0003
638 GASTROENTERITIS 4 0.0003
639 WOUND INFECTION 3 0.0003
640 ASPIRATION 3 0.0003
641 LABORATORY TEST ABNORMAL 8 0.0003
642 PSYCHIATRIC SYMPTOM 2 0.0003
643 BONE DENSITY ABNORMAL 1 0.0003
644 EPISTAXIS 20 0.0003
645 TUBULOINTERSTITIAL NEPHRITIS 5 0.0003
646 EYE INFECTION 3 0.0003
647 HYPERTHERMIA 2 0.0003
648 PULMONARY FIBROSIS 5 0.0003
649 PNEUMONITIS 7 0.0003
650 PULMONARY HAEMORRHAGE 2 0.0003
651 ELECTROCARDIOGRAM ABNORMAL 2 0.0003
652 BLEPHARITIS 1 0.0002
653 STOMATITIS 15 0.0002
654 NEURALGIA 6 0.0002
655 HYPERCALCAEMIA 3 0.0002
656 VENTRICULAR TACHYCARDIA 4 0.0002
657 AORTIC DISSECTION 1 0.0002
658 HAIR COLOUR CHANGES 3 0.0002
659 HEMIPLEGIA 2 0.0002
660 METASTASES TO CENTRAL NERVOUS SYSTEM 3 0.0002
661 INFLAMMATION 12 0.0002
662 HEPATIC FAILURE 7 0.0002
663 BLOOD MAGNESIUM DECREASED 2 0.0002
664 HYPONATRAEMIA 13 0.0002
665 PLATELET COUNT INCREASED 3 0.0002
666 PRODUCT PRESCRIBING ISSUE 5 0.0002
667 NEUROTOXICITY 4 0.0002
668 BEDRIDDEN 3 0.0002
669 EYE HAEMORRHAGE 3 0.0002
670 HEART RATE IRREGULAR 5 0.0002
671 DYSPHAGIA 21 0.0002
672 ACUTE HEPATIC FAILURE 3 0.0002
673 SKIN LESION 6 0.0002
674 DRUG INEFFECTIVE FOR UNAPPROVED INDICATION 12 0.0002
675 SHOCK 5 0.0002
676 ARTHRITIS INFECTIVE 1 0.0002
677 ERYTHEMA MULTIFORME 2 0.0002
678 BLINDNESS UNILATERAL 3 0.0002
679 SINUS TACHYCARDIA 3 0.0002
680 THERAPEUTIC PRODUCT EFFECT INCOMPLETE 15 0.0002
681 VIRAL INFECTION 7 0.0002
682 PARALYSIS 3 0.0002
683 CONDITION AGGRAVATED 63 0.0002
684 LOCALISED INFECTION 5 0.0002
685 CARDIAC ARREST 17 0.0002
686 ORAL HERPES 4 0.0002
687 ASCITES 6 0.0002
688 VITREOUS FLOATERS 2 0.0002
689 LIGAMENT SPRAIN 2 0.0002
690 HAEMATOCRIT DECREASED 4 0.0002
691 PULMONARY MASS 3 0.0002
692 ABDOMINAL TENDERNESS 1 0.0002
693 BLOOD PRESSURE ABNORMAL 4 0.0002
694 HAEMORRHAGE 21 0.0002
695 DRUG LEVEL DECREASED 2 0.0002
696 NEUTROPHIL COUNT INCREASED 2 0.0002
697 HOSPITALISATION 30 0.0002
698 TEMPERATURE INTOLERANCE 2 0.0002
699 HERPES ZOSTER 11 0.0002
700 DEAFNESS 5 0.0002
701 PRODUCT USE IN UNAPPROVED INDICATION 47 0.0002
702 DEPRESSED MOOD 10 0.0002
703 SUDDEN DEATH 2 0.0002
704 METABOLIC ACIDOSIS 6 0.0002
705 RASH 81 0.0002
706 PAIN OF SKIN 5 0.0002
707 LACTIC ACIDOSIS 6 0.0002
708 FAECES DISCOLOURED 4 0.0002
709 OSTEONECROSIS 6 0.0002
710 GAIT INABILITY 6 0.0002
711 MALNUTRITION 2 0.0002
712 NEPHROPATHY TOXIC 2 0.0002
713 REBOUND EFFECT 2 0.0002
714 FLUID RETENTION 9 0.0002
715 MYOCARDIAL ISCHAEMIA 2 0.0002
716 PRODUCT AVAILABILITY ISSUE 4 0.0002
717 RENAL DISORDER 8 0.0002
718 SPLENOMEGALY 2 0.0002
719 BLOOD TRIGLYCERIDES INCREASED 3 0.0002
720 LYMPHOCYTE COUNT DECREASED 3 0.0002
721 ACUTE MYOCARDIAL INFARCTION 5 0.0002
722 ATAXIA 2 0.0002
723 RENAL INJURY 5 0.0002
724 ACCIDENT 2 0.0002
725 POLYNEUROPATHY 2 0.0002
726 OSTEOMYELITIS 3 0.0002
727 HYPOGLYCAEMIA 8 0.0002
728 ADRENAL INSUFFICIENCY 2 0.0002
729 DYSURIA 6 0.0002
730 RECTAL HAEMORRHAGE 7 0.0002
731 EYE SWELLING 6 0.0002
732 HEPATIC STEATOSIS 3 0.0002
733 BLOOD SODIUM DECREASED 3 0.0002
734 HYPOCALCAEMIA 3 0.0002
735 BRAIN OEDEMA 2 0.0002
736 HAEMORRHOIDS 3 0.0002
737 BRADYPHRENIA 1 0.0002
738 TOOTH INFECTION 2 0.0002
739 PANCREATITIS 8 0.0002
740 APPETITE DISORDER 1 0.0002
741 ATRIOVENTRICULAR BLOCK COMPLETE 1 0.0001
742 FEEDING DISORDER 3 0.0001
743 LIMB INJURY 4 0.0001
744 DECREASED APPETITE 34 0.0001
745 RIB FRACTURE 3 0.0001
746 PERIPHERAL COLDNESS 2 0.0001
747 DIVERTICULITIS 4 0.0001
748 RHABDOMYOLYSIS 6 0.0001
749 RENAL FAILURE 19 0.0001
750 HYPERKALAEMIA 5 0.0001
751 BLOOD TEST ABNORMAL 2 0.0001
752 SKIN REACTION 2 0.0001
753 HYPERTENSION 30 0.0001
754 SEASONAL ALLERGY 2 0.0001
755 LYMPHADENOPATHY 5 0.0001
756 FLUID OVERLOAD 2 0.0001
757 INTERVERTEBRAL DISC PROTRUSION 3 0.0001
758 HYPERGLYCAEMIA 5 0.0001
759 APATHY 2 0.0001
760 DRUG EFFECT LESS THAN EXPECTED 2 0.0001
761 COLON CANCER 2 0.0001
762 ATRIAL FIBRILLATION 13 0.0001
763 DYSPNOEA EXERTIONAL 5 0.0001
764 INSURANCE ISSUE 2 0.0001
765 SYNCOPE 13 0.0001
766 HYPOTENSION 26 0.0001
767 ATRIOVENTRICULAR BLOCK 1 0.0001
768 MUSCULOSKELETAL CHEST PAIN 2 0.0001
769 RASH PRURITIC 7 0.0001
770 URINARY TRACT INFECTION 22 0.0001
771 PNEUMOTHORAX 2 0.0001
772 BLOOD ALBUMIN DECREASED 1 0.0001
773 PRODUCT PRESCRIBING ERROR 3 0.0001
774 DIARRHOEA 81 0.0001
775 ABSCESS 2 0.0001
776 HIP FRACTURE 4 0.0001
777 MYALGIA 21 0.0001
778 BLOOD POTASSIUM INCREASED 2 0.0001
779 ASPHYXIA 1 0.0001
780 SEIZURE 14 0.0001
781 ACUTE CORONARY SYNDROME 1 0.0001
782 SKIN DISORDER 4 0.0001
783 URINARY RETENTION 4 0.0001
784 TYPE 2 DIABETES MELLITUS 4 0.0001
785 GASTRIC CANCER 3 0.0001
786 ASTHENIA 44 0.0001
787 ERECTILE DYSFUNCTION 3 0.0001
788 DELIRIUM 4 0.0001
789 NEOPLASM PROGRESSION 4 0.0001
790 OEDEMA PERIPHERAL 14 0.0001
791 ORTHOSTATIC HYPOTENSION 2 0.0001
792 DRUG INEFFECTIVE 151 0.0001
793 BLOOD CALCIUM INCREASED 1 0.0001
794 BRADYCARDIA 6 0.0001
795 GALLBLADDER DISORDER 2 0.0001
796 JAUNDICE 3 0.0001
797 TOOTHACHE 2 0.0001
798 CONSTIPATION 24 0.0001
799 HAEMATOCHEZIA 6 0.0001
800 BLOOD THYROID STIMULATING HORMONE INCREASED 1 0.0001
801 BLOOD GLUCOSE ABNORMAL 2 0.0001
802 UPPER RESPIRATORY TRACT INFECTION 5 0.0001
803 MENTAL STATUS CHANGES 3 0.0001
804 CONJUNCTIVITIS 2 0.0001
805 INFLUENZA 12 0.0001
806 SINUSITIS 11 0.0001
807 INTESTINAL OBSTRUCTION 4 0.0001
808 UNEVALUABLE EVENT 8 0.0001
809 FRACTURE 2 0.0001
810 MUSCULAR WEAKNESS 12 0.0001
811 ARRHYTHMIA 5 0.0001
812 BLOOD URINE PRESENT 2 0.0001
813 BLOOD PRESSURE DECREASED 7 0.0001
814 PROTEINURIA 2 0.0001
815 NEUROPATHY PERIPHERAL 10 0.0001
816 INCREASED APPETITE 2 0.0001
817 DRUG INTOLERANCE 10 0.0001
818 CATARACT 6 0.0001
819 BRAIN INJURY 1 0.0001
820 EPILEPSY 3 0.0001
821 EMOTIONAL DISORDER 3 0.0001
822 TREATMENT FAILURE 8 0.0001
823 CARDIAC DISORDER 9 0.0001
824 MUSCULOSKELETAL PAIN 5 0.0001
825 HEAD INJURY 3 0.0001
826 CYSTITIS 3 0.0001
827 HYPOTHYROIDISM 3 0.0001
828 RETCHING 2 0.0001
829 HYPOAESTHESIA 14 0.0001
830 DEEP VEIN THROMBOSIS 6 0.0001
831 NAUSEA 73 0.0001
832 DIZZINESS 46 0.0001
833 PRODUCT DISPENSING ERROR 2 0.0001
834 IMPAIRED HEALING 3 0.0001
835 NEOPLASM MALIGNANT 6 0.0001
836 PANCREATITIS ACUTE 2 0.0001
837 TOXICITY TO VARIOUS AGENTS 15 0.0001
838 CHROMATURIA 2 0.0001
839 ILLNESS 9 0.0001
840 FALL 29 0.0001
841 THROMBOSIS 7 0.0001
842 DRY MOUTH 7 0.0001
843 PALMAR-PLANTAR ERYTHRODYSAESTHESIA SYNDROME 2 0.0001
844 COUGH 24 0.0001
845 BONE PAIN 5 0.0001
846 RASH ERYTHEMATOUS 4 0.0001
847 MOBILITY DECREASED 6 0.0001
848 HEPATIC CANCER 2 0.0001
849 MENTAL IMPAIRMENT 2 0.0001
850 FATIGUE 63 0.0001
851 CONFUSIONAL STATE 13 0.0001
852 WEIGHT INCREASED 18 0.0001
853 DYSARTHRIA 3 0.0001
854 HAEMATEMESIS 2 0.0001
855 HYPOPHAGIA 2 0.0001
856 UNRESPONSIVE TO STIMULI 2 0.0001
857 SKIN ULCER 2 0.0001
858 SWELLING FACE 5 0.0001
859 SPEECH DISORDER 4 0.0001
860 DEPRESSED LEVEL OF CONSCIOUSNESS 3 0.0001
861 OROPHARYNGEAL PAIN 7 0.0001
862 FREQUENT BOWEL MOVEMENTS 2 0.0001
863 MOOD ALTERED 2 0.0001
864 CONTUSION 7 0.0001
865 RESPIRATORY DISTRESS 2 0.0001
866 CARDIO-RESPIRATORY ARREST 3 0.0001
867 DYSPNOEA 40 0.0001
868 LOSS OF CONSCIOUSNESS 9 0.0001
869 VOMITING 33 0.0001
870 CHEST PAIN 13 0.0001
871 SKIN BURNING SENSATION 5 0.0001
872 WRONG TECHNIQUE IN PRODUCT USAGE PROCESS 14 0.0001
873 DRUG EFFECTIVE FOR UNAPPROVED INDICATION 2 0.0001
874 CHILLS 8 0.0001
875 ERYTHEMA 14 0.0001
876 BRONCHITIS 5 0.0001
877 DYSGEUSIA 5 0.0001
878 GASTROINTESTINAL DISORDER 6 0.0001
879 MALAISE 29 0.0001
880 BLOOD COUNT ABNORMAL 1 0.0001
881 ILL-DEFINED DISORDER 4 0.0001
882 VISION BLURRED 9 0.0001
883 MEMORY IMPAIRMENT 9 0.0001
884 SOMNOLENCE 13 0.0001
885 VISUAL IMPAIRMENT 8 0.0001
886 COGNITIVE DISORDER 3 0.0001
887 SWELLING 6 0.0001
888 BASAL CELL CARCINOMA 1 0.0001
889 BRAIN FOG 1 0.0001
890 PULMONARY EMBOLISM 6 0.0001
891 MOOD SWINGS 2 0.0001
892 NIGHT SWEATS 2 0.0001
893 CHOLELITHIASIS 2 0.0001
894 EYE DISORDER 2 0.0001
895 ABDOMINAL PAIN 14 0.0001
896 EXPIRED PRODUCT ADMINISTERED 2 0.0001
897 ABDOMINAL DISCOMFORT 10 0.0001
898 ANGER 2 0.0001
899 BLOOD PRESSURE INCREASED 9 0.0001
900 GASTRIC DISORDER 2 0.0001
901 PARAESTHESIA 9 0.0001
902 PRODUCT STORAGE ERROR 5 0.0001
903 INTENTIONAL PRODUCT USE ISSUE 5 0.0001
904 CRYING 2 0.0001
905 TREATMENT NONCOMPLIANCE 3 0.0001
906 RESTLESSNESS 2 0.0001
907 PRURITUS 21 0.0001
908 TREMOR 9 0.0001
909 ARTHRALGIA 22 0.0001
910 DEHYDRATION 7 0.0001
911 LETHARGY 3 0.0001
912 PERIPHERAL SWELLING 8 0.0001
913 BLOOD PRESSURE SYSTOLIC INCREASED 1 0.0001
914 ARTHRITIS 4 0.0001
915 ABNORMAL BEHAVIOUR 2 0.0001
916 DISORIENTATION 2 0.0001
917 HEART RATE INCREASED 5 0.0001
918 GASTROOESOPHAGEAL REFLUX DISEASE 4 0.0000
919 VERTIGO 3 0.0000
920 BLINDNESS 2 0.0000
921 LUNG NEOPLASM MALIGNANT 2 0.0000
922 OSTEOPOROSIS 2 0.0000
923 HYPERSENSITIVITY 9 0.0000
924 POLLAKIURIA 2 0.0000
925 ROAD TRAFFIC ACCIDENT 2 0.0000
926 PAIN IN EXTREMITY 14 0.0000
927 INTENTIONAL OVERDOSE 3 0.0000
928 BALANCE DISORDER 4 0.0000
929 VAGINAL HAEMORRHAGE 2 0.0000
930 MENTAL DISORDER 2 0.0000
931 APPLICATION SITE PAIN 1 0.0000
932 THERAPEUTIC PRODUCT EFFECT DECREASED 2 0.0000
933 ADVERSE DRUG REACTION 4 0.0000
934 INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION 8 0.0000
935 LOWER RESPIRATORY TRACT INFECTION 2 0.0000
936 PAIN 27 0.0000
937 SKIN DISCOLOURATION 2 0.0000
938 OCULAR HYPERAEMIA 2 0.0000
939 COMA 2 0.0000
940 MIGRAINE 4 0.0000
941 GAIT DISTURBANCE 8 0.0000
942 BLOOD PRESSURE FLUCTUATION 1 0.0000
943 PRODUCT DOSE OMISSION ISSUE 12 0.0000
944 AGEUSIA 1 0.0000
945 DRY EYE 2 0.0000
946 HOT FLUSH 3 0.0000
947 DIABETES MELLITUS 3 0.0000
948 CHRONIC OBSTRUCTIVE PULMONARY DISEASE 2 0.0000
949 HEADACHE 24 0.0000
950 ECZEMA 2 0.0000
951 NASOPHARYNGITIS 7 0.0000
952 INSOMNIA 10 0.0000
953 BLISTER 2 0.0000
954 OXYGEN SATURATION DECREASED 2 0.0000
955 EYE PAIN 2 0.0000
956 CEREBROVASCULAR ACCIDENT 6 0.0000
957 BACK PAIN 8 0.0000
958 MYOCARDIAL INFARCTION 6 0.0000
959 NASAL CONGESTION 2 0.0000
960 MATERNAL EXPOSURE DURING PREGNANCY 3 0.0000
961 FEELING HOT 2 0.0000
962 OVERDOSE 7 0.0000
963 WEIGHT DECREASED 9 0.0000
964 EXPOSURE DURING PREGNANCY 2 0.0000
965 HYPERHIDROSIS 4 0.0000
966 RHINORRHOEA 2 0.0000
967 ALOPECIA 6 0.0000
968 DRY SKIN 4 0.0000
969 FEELING ABNORMAL 7 0.0000
970 BURNING SENSATION 2 0.0000
971 THERAPY INTERRUPTED 2 0.0000
972 HALLUCINATION 2 0.0000
973 PALPITATIONS 3 0.0000
974 CARDIAC FAILURE CONGESTIVE 2 0.0000
975 SKIN EXFOLIATION 2 0.0000
976 NO ADVERSE EVENT 4 0.0000
977 ANXIETY 6 0.0000
978 BLOOD GLUCOSE DECREASED 1 0.0000
979 DYSPEPSIA 2 0.0000
980 CHEST DISCOMFORT 2 0.0000
981 ARTHROPATHY 1 0.0000
982 URTICARIA 3 0.0000
983 ASTHMA 2 0.0000
984 INCORRECT DOSE ADMINISTERED 4 0.0000
985 EMOTIONAL DISTRESS 2 0.0000
986 BLOOD GLUCOSE INCREASED 3 0.0000
987 AMNESIA 1 0.0000
988 ABDOMINAL PAIN UPPER 3 0.0000
989 ACNE 1 0.0000
990 MUSCLE SPASMS 2 0.0000
991 ADVERSE EVENT 1 0.0000
992 ABDOMINAL DISTENSION 1 0.0000
993 DEPRESSION 2 0.0000